Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta -Lactamases: which ones are clinically important?

Louis B. Rice1, Robert A. Bonomo

  • 1Medical Service, Department of Veterans Affairs Medical Center, Departments of Medicine, Pharmacology, Case Western Reserve University, Cleveland, Ohio, USA

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|August 11, 2001
PubMed
Summary

Beta-lactamase enzymes confer bacterial resistance to antibiotics. This review focuses on clinically significant Ambler Class A, C, and B beta-lactamases, particularly metallo-beta-lactamases hydrolyzing carbapenems.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Therapy-induced microenvironmental senescence in tumor treatment resistance: From mechanism to therapy.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Targeting LIG1 to overcome oxaliplatin resistance by inducing PANoptosis in colorectal cancer.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Long-term outcomes and exploratory analysis from a randomized phase 3 trial of radiation dose escalation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Mechanistic analysis on epigenetic programming of tumor drug resistance.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Development and clinical application of a primary cancer organoid-PBMC co-culture system for personalized immunotherapy.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Perioperative tislelizumab for early-stage hepatocellular carcinoma: A phase II trial with integrated tumour microenvironment profiling and predictive modeling.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Beta-lactam antibiotics have driven the evolution of diverse beta-lactamase enzymes for bacterial resistance.
  • These enzymes are produced by both Gram-positive and Gram-negative bacteria, with greater clinical significance in Gram-negatives.
  • The expanding diversity of beta-lactamases can be confusing; this review focuses on clinically relevant enzymes.

Purpose of the Study:

  • To clarify the landscape of clinically important beta-lactamases.
  • To focus on Ambler Class A and C beta-lactamases.
  • To highlight the increasing threat of Ambler Class B metallo-beta-lactamases.

Main Methods:

  • Literature review and synthesis of existing research on beta-lactamases.
  • Focus on enzymes with significant clinical impact.

Related Experiment Videos

  • Categorization based on the Ambler classification system.

    • Main Results:

    • Ambler Class A and C beta-lactamases are of primary clinical importance.
    • Ambler Class B metallo-beta-lactamases are increasingly prevalent.
    • Metallo-beta-lactamases hydrolyze carbapenems, a critical class of antibiotics.

    Conclusions:

    • Understanding clinically relevant beta-lactamases is crucial for effective antibiotic therapy.
    • The rise of carbapenem-hydrolyzing metallo-beta-lactamases necessitates attention.
    • Continued research and surveillance are vital to combat antimicrobial resistance.